Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
iRhythm Technologies Inc Market Cap
Based on ratings from 6 stock analysts, the iRhythm Technologies Inc stock price is expected to increase by 12.93% in 12 months. This is calculated by using the average 12-month stock price forecast for iRhythm Technologies Inc. The lowest target is $110.00 and the highest is $145.00. Please note analyst price targets are not guaranteed and could be missed completely.
IRTC is a stock in Health Care which has been forecasted to be worth $126.67 as an average. On the higher end, the forecast price is $145.00 USD by richard newitter from Truist Financial and on the lower end IRTC is forecasted to be $110.00 by joanne wuensch from Citi.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| richard newitter Truist Financial | Buy | $145.0 | maintained | Jan 30, 2024 |
| nathan treybeck Wells Fargo | Buy | $125.0 | maintained | Jan 9, 2024 |
| william plovanic Canaccord Genuity | Buy | $121.0 | maintained | Jan 8, 2024 |
| joanne wuensch Citi | Buy | $110.0 | reiterated | Jan 8, 2024 |
| david saxon Needham | Buy | $136.0 | reiterated | Jan 8, 2024 |
| allen gong J.P. Morgan | Buy | $123.0 | maintained | Dec 18, 2023 |
| cecilia furlong Morgan Stanley | Buy | $125.0 | maintained | Nov 6, 2023 |
| kallum titchmarsh Morgan Stanley | Buy | $125.0 | maintained | Nov 6, 2023 |
| robbie marcus J.P. Morgan | Buy | $111.0 | maintained | Nov 3, 2023 |
| david rescott Robert W. Baird | Buy | $94.0 | maintained | Nov 3, 2023 |
| suraj kalia Oppenheimer | Buy | $165.0 | maintained | Nov 3, 2023 |
| marie thibault BTIG | Buy | $132.0 | maintained | Nov 2, 2023 |
| ryan zimmerman BTIG | Buy | $132.0 | maintained | Oct 16, 2023 |
| michael polark Wolfe Research | Hold | None | upgraded | Nov 7, 2022 |
| eugene mannheimer Colliers Securities | Hold | None | maintained | Jul 15, 2021 |
| margaret kaczor William Blair | Buy | None | maintained | Jan 29, 2021 |
| brandon henry RBC Capital | Buy | $109.0 | maintained | Nov 6, 2019 |
| steven wardell Chardan Capital | Hold | $104.0 | downgraded | Feb 20, 2019 |
| glenn novarro RBC Capital | Buy | $109.0 | maintained | Feb 13, 2019 |
| michael weinstein J.P. Morgan | Buy | $34.0 | initiatedcoverage | Nov 14, 2016 |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
When did it IPO
2016
Staff Count
1,793
Country
United States
Sector/Industry
Healthcare/Medical Devices
CEO
Mr. Quentin S. Blackford
Market Cap
$3.50B
In 2023, IRTC generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that IRTC's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
$12.39
ITRI-USD
$75.4
$45.2
PCH-USD
$44.29
AVAV-USD
$123.75
BL-USD
$56.72
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
